FAP and neoplasm: Furthermore, the chelates [177Lu]-PNT6555, PNT6952, and PNT6522 exhibited significant antitumor effects in FAP-positive tumor models, with [177Lu]-PNT6555 demonstrating the highest therapeutic efficacy, substantiating its potential as a promising candidate for radioligand therapy [119].